+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Notch receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Notch receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Discoidin domain receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Discoidin domain receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Proto oncogene protein c-myc inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto oncogene protein c-myc inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 96 Pages
  • Global
From
Proto oncogene proteins c pim 1 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto oncogene proteins c pim 1 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Proto-oncogene protein c-bcl-2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto-oncogene protein c-bcl-2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
LAG-3 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

LAG-3 Antagonist - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
P53 Antigen Modulators - Pipeline Insight, 2024 - Product Thumbnail Image

P53 Antigen Modulators - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
TIGIT inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

TIGIT inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Proto oncogene protein c-akt inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto oncogene protein c-akt inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
CD47 antigen inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

CD47 antigen inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
BET inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

BET inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
CDK9 inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CDK9 inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
CD137 Agonist Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

CD137 Agonist Antibody - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
CALQUENCE Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

CALQUENCE Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • Global
From
BREYANZI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

BREYANZI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • Global
From
MONJUVI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

MONJUVI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • Global
From
ZYNLONTA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ZYNLONTA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • Global
From
POLIVY Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

POLIVY Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • Global
From
EPKINLY Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

EPKINLY Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more